SCHEMBL6828519

SCHEMBL6828519

CCOC(=O)c1[nH]c(C)c(-c2ccc(C(=O)Nc3ccccc3OC)cc2)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
LMNA P02545 4/20 0.53
HTT P42858 4/20 0.53
RAB9A P51151 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 1/20 0.53
MAPT P10636 5/20 0.52
NPC1 O15118 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
APOBEC3G Q9HC16 2/20 0.50
GAA P10253 1/20 0.50
KDM4E B2RXH2 2/20 0.48
PABPC1 P11940 1/20 0.48
APOBEC3A P31941 1/20 0.48
EIF4H Q15056 1/20 0.48
MLYCD O95822 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6825121 0.87 LMNA (0.54) L3MBTL1KMT2AMEN1LMNAHTT
SCHEMBL6828204 0.87 SMN1; SMN2 (0.70) L3MBTL1KMT2AMEN1LMNAHTT
SCHEMBL6825524 0.84 HTT (0.66) KMT2AMEN1LMNAHTTALDH1A1
SCHEMBL6828203 0.84 MAPT (0.60) KMT2AMEN1LMNAHTTRAB9A
SCHEMBL6828198 0.82 MAPT (0.60) KMT2AMEN1LMNAHTTRAB9A
SCHEMBL6830213 0.82 KDM4E (0.59) RXFP1KMT2AMEN1LMNAHTT
SCHEMBL6828196 0.78 LMNA (0.53) L3MBTL1KMT2AMEN1LMNAHTT
SCHEMBL6825618 0.78 MAPT (0.60) KMT2AMEN1LMNAHTTRAB9A
SCHEMBL6825631 0.78 LMNA (0.58) KMT2ALMNAHTTRAB9AALDH1A1
SCHEMBL6825632 0.77 MAPT (0.52) L3MBTL1KMT2AMEN1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138269-A1 Substituted pyrroles as kinase inhibitors SUGEN, INC. 2004-07-15 US claimed
US-20040138269-A1 Substituted pyrroles as kinase inhibitors SUGEN, INC. 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138269-A1 Substituted pyrroles as kinase inhibitors PHKG1, PHKG2, MAP3K20 RXFP1 4353/4885L3MBTL1 3945/4885KMT2A 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.